Delivery Order SPE2DB22D2007-SPE2DB25FJ3UU
- Not listed
- The Defense Logistics Agency awarded a $1,833.32 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award is not set-aside and was competitively awarded, reflecting the contractor's...
- The Defense Logistics Agency awarded a $7,804.29 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injection). This contract represents a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. As a leading pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,087.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) under a firm fixed-price contract. This non-set-aside award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a single delivery transaction for pharmaceutical supplies to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,601.43 to supply Forteo (teriparatide) 560 mcg/2.24 mL pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 31, 2025, and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $10,392.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 ml pen injections) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections) with a ceiling value of $16,198.68. This firm fixed-price delivery order, which is due for completion by August 8, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award utilized no set-aside designation and was competitively awarded. The pharmaceutical...
- The Defense Logistics Agency awarded a $10,405.72 delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Conshohocken, Pennsylvania corporate office. The delivery order represents a single transaction under AmerisourceBergen Drug Corp's broader federal contract...
- The Defense Logistics Agency awarded a delivery order valued at $62,529.46 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections). This firm fixed-price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-competitive, non-set-aside procurement from the vendor's place of performance in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $2,601.43 delivery order to AmerisourceBergen Drug Corp for Forteo 560 mcg/2.24 mL pen injections on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order represents a pediatric pharmaceutical supply requirement fulfilled through competitive procurement with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,054.76 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3UUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,554.97 to AmerisourceBergen Drug Corp for the supply of Forteo (teriparatide) 560 mcg/2.24 mL pen injections on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price, non-set-aside delivery order is being performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's broader pharmaceutical distribution portfolio supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 billion through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a wide range of medical products including brand-name and generic medications, vaccines, and specialized medical supplies to support military and veteran healthcare systems. The vendor's consistent success in competitively awarded federal contracts demonstrates its capability to fulfill diverse federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 8/8/25 |